Non-renal causes of anemia in elderly (≥ 65) patients with chronic kidney disease (CKD).

被引：0
|
作者：
McClellan, WM
Woodman, RC
Hill, K
Blasi, MV
Klausner, MA
机构：
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Ortho Biotech Prod LP, Clin Affairs, Bridgewater, NJ USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3769
引用
收藏
页码：17B / 17B
页数：1
相关论文
共 50 条
  • [21] Anemia and adverse outcomes in veterans with chronic kidney disease (CKD)
    Seliger, SL
    Sampson, J
    Kestenbaum, B
    Young, B
    Rudser, K
    Andress, DL
    Sherrard, DJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A46 - A46
  • [22] Anemia Management Considering the Pathophysiology of Elderly Chronic Kidney Disease Patients
    Kuragano, Takahiro
    Mizusaki, Kousuke
    Kimura, Tomoko
    Nakanishi, Takeshi
    CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 135 - 143
  • [23] Risk Factors for Chronic Kidney Disease in Pediatric Non-Renal Solid Organ Transplant Recipients
    Choi, J.
    Vasilevska-Ristovska, J.
    Ng, V.
    Dipchand, A.
    Solomon, M.
    Hebert, D.
    Kim, S.
    Parekh, R.
    TRANSPLANTATION, 2014, 98 : 238 - 238
  • [24] Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)
    Hayashi, Terumasa
    Uemura, Yukari
    Kumagai, Michiko
    Kimpara, Masashi
    Kanno, Hiroyuki
    Ohashi, Yasuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (03) : 349 - 361
  • [25] Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)
    Terumasa Hayashi
    Yukari Uemura
    Michiko Kumagai
    Masashi Kimpara
    Hiroyuki Kanno
    Yasuo Ohashi
    Clinical and Experimental Nephrology, 2019, 23 : 349 - 361
  • [26] Prevalence of chronic kidney disease (CKD) in patients referred to a hematologist for anemia: An epidemic problem
    Brian, Zimmer
    Dana, Wentzel
    James, Reed
    Elliott, Friedman
    Basil, Ahmed
    Nelson, Kopyt
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A86 - A86
  • [27] Cardiovascular and renal complications among patients with chronic kidney disease (CKD) in the Netherlands
    Overbeek, Jetty
    de Jong, Hilda J.
    Oudenhuijzen-Taanman, Martine
    Pander, Jan
    Penning-van Beest, Fernie J.
    Oudenhuijzen, Martine
    Vervloet, Marc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 413 - 413
  • [28] Anemia in chronic kidney disease: Causes, diagnosis, treatment
    Nurko, S
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (03) : 289 - 297
  • [29] Renoprotective Effects of Daprodustat in Patients with Chronic Kidney Disease and Renal Anemia
    Shimada, Yoshitaka
    Izumi, Yuichiro
    Yasuoka, Yukiko
    Oshima, Tomomi
    Nagaba, Yasushi
    Nanami, Masayoshi
    Sands, Jeff M.
    Takahashi, Noriko
    Kawahara, Katsumasa
    Nonoguchi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [30] The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease
    Wu, Chih-Jen
    Chen, Cheng-Yi
    Lai, Thung-S.
    Wu, Pei-Chen
    Chuang, Chih-Kuang
    Sun, Fang-Ju
    Liu, Hsuan-Liang
    Chen, Han-Hsiang
    Yeh, Hung-I.
    Lin, Chih-Sheng
    Lin, Cheng-Jui
    ONCOTARGET, 2017, 8 (47) : 83030 - 83037
12345